Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride safely treats hair loss without harming sexual function.

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.

Different forms of finasteride dissolve and remain stable differently, affecting capsule quality.

Finasteride may cause male infertility, stopping it can help.

Finasteride can cause sexual problems and depression in young men.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Some skin, hair, and nail supplements can be toxic, interact with medications, affect lab tests, and may increase cancer risk.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Post-finasteride syndrome's existence is uncertain; more research needed.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Women experience more side effects and have worse blood pressure control from hypertension treatments than men, despite using different medications.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Finasteride and minoxidil are the main effective treatments for hair loss from androgenetic alopecia.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Saw palmetto extract is generally safe and can effectively treat Lower Urinary Tract Symptoms, but its evaluation is affected by varying quality and a need for long-term studies.

New oral treatment, finasteride, effectively and safely treats common hair loss.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

The document covers various male health issues, their causes, treatments, and related conditions.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Quick, selective detection of tadalafil and finasteride in human plasma developed.